Calumet, a specialty chemicals and biofuels player, gained more than 100% from the 52-week low a couple of months ago. Find ...

Bright Horizons' recovery strategy positions it for continued margin and revenue growth. Click here to see why BFAM stock is ...

Dividend stocks paying great yields have historically traded at premium valuations, but the current environment has been ...

We don't expect Proximus will reach EUR 300 million in free cash flow to the firm until after 2030. Proximus can achieve some cost efficiencies to offset any revenue declines in the future, but we don ...